In line with this, Scolari et al. observed a 1.5-fold increased prevalence of CHIP-mutations, particularly TET2 and ASXL1, among patients with cardiogenic shock predominantly of non-ischemic origin, compared to HF patients (95% CI 1.0–2.1). Here, TET2 is linked to hydrops fetalis.